1201186-86-8

Basic information

• Product Name: 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylic acid
• Synonyms: 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylic acid
• CAS NO: 1201186-86-8
• Molecular Formula: C13H21NO4
• Molecular Weight: 255.31014
• EINECS: -0
• Mol File: 1201186-86-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylic acid(1201186-86-8)
• EPA Substance Registry System: 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylic acid(1201186-86-8)

Safety Data

• Hazardous Substances Data: 1201186-86-8(Hazardous Substances Data)

Upstream product

• 15448-76-7 dimethyl bicyclo<2.2.1>heptane-1,4-dicarboxylate 
• 15448-77-8 4-carbomethoxybicyclo<2.2.1>heptane-1-carboxylic acid 
• 1252672-35-7 4-(benzyloxycarbonylamino)bicyclo[2.2.1]heptane-1-carboxylic acid methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 1384427-36-4 4-aminobicyclo[2.2.1]heptane-1-carboxylic acid hydrochloride 
• 1201186-85-7 methyl 4-((tert-butoxycarbonyl)amino)bicyclo[2.2.1]heptane-1-carboxylate 

Relevant articles and documents

SULFINYLAMINOBENZAMIDE AND SULFONYLAMINOBENZAMIDE DERIVATIVES

Provided is a compound of Formula (I): wherein the variable groups are defined herein.

Small Molecule Inhibitors of the JAK Family of Kinases

2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK, such as inflammatory bowel disease.

Novel Tricyclic Compounds

The invention provides a compound of Formula (I) pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.